SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 203.80+1.2%11:25 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (17572)3/18/1998 10:48:00 PM
From: SnowShredder  Read Replies (1) of 32384
 
Personally, I think the LGND did ok on this deal. The management are playing it safe because there is no guarantee that any of the products in pipeline are going to be approved. Even if the products get approved there is no guarantee that they will reach expectations in sales immediately (look @ Evista). I think they are hedging there bets, against a worst case scenario, none of the products that are supposed to make this stock profitable in the near term do this and LGND is still in the red. This deal is kinda like a guarantee (@ least for a little while) that they will have enough $$$$ to fund research and trials til they get into the green. I feel that once LGND becomes profitable new collaborations will stop and LGND will have all of the new cake to itself (How greedy :) (IMHO)

Just so you know I'm biased...I'm long on LGND (>50% LGNDW...I'm a gambler).

Henry, if they find a non obesity use for the leptin drug, does SBH retain the rights & LGND gets royalties, or does LGND gets the rights for that use?

Go LGND,

Where'd He Go?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext